David-Alexandre C. Gros

Overview

David-Alexandre C. Gros received an average of $3.8M in compensation at Alnylam Pharmaceuticals from 2015 to 2017.

Source: SEC filings on March 23, 2018 and March 17, 2016.

Related executives

We found 11 more executives who work or worked at Alnylam Pharmaceuticals.

Manmeet Soni

Alnylam Pharmaceuticals

Chief Financial Officer

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

Yvonne Greenstreet

Alnylam Pharmaceuticals

Chief Operating Officer

Barry Greene

Alnylam Pharmaceuticals

President

Akshay Vaishnaw

Alnylam Pharmaceuticals

President, Research and Development

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer former principal financial officer

Laurie Keating

Alnylam Pharmaceuticals

General Counsel

Laurence Reid

Alnylam Pharmaceuticals

Senior Vice President and Chief Business Officer

You may also like